Cargando...
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
BACKGROUND: Cisplatin (DDP)-based chemotherapy is the mainstay of first-line therapy for lung cancer. However, their efficacy is often limited by the existence or development of chemoresistance. The aim of this study was to find and investigate the function of miRNAs in cisplatin (DDP)-resistant non...
Guardado en:
| Publicado en: | Cancer Cell Int |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4828824/ https://ncbi.nlm.nih.gov/pubmed/27073334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0305-6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|